PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase

Chandra Bartholomeusz(The University of Texas MD Anderson Cancer Center), Naoto T. Ueno(Breast Cancer Care)

Clinical Cancer Research

March 10, 2010

10.1158/1078-0432.ccr-09-1456

Cited by 64

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

|New England Journal of Medicine|2022|2.5k

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

|Journal of Clinical Oncology|1998|927

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

|Blood|2001|570

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

|Blood|2001|516

A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer

|Molecular Endocrinology|2010|232